Patient Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$82.3M |
| 2 |
Coinbase
COIN
|
+$49.5M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$47.6M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$43.9M |
| 5 |
UnitedHealth
UNH
|
+$20.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mattel
MAT
|
+$55.4M |
| 2 |
Biogen
BIIB
|
+$36.2M |
| 3 |
Fidelity Wise Origin Bitcoin Fund
FBTC
|
+$28.5M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$15M |
| 5 |
Alibaba
BABA
|
+$14.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.53% |
| 2 | Consumer Discretionary | 16.47% |
| 3 | Communication Services | 13.6% |
| 4 | Financials | 13% |
| 5 | Technology | 11.13% |
Similar funds
Patient Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, Patient Capital Management held 44 positions worth $2.74B, up 5.6% from $2.59B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Patient Capital Management deployed $246M of net new capital in Q1 2026, opening 4 new positions and adding to 23 existing holdings. Its largest new stake was Adobe: 297,279 shares worth $72.3M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Biogen, an estimated $36.2M trimmed.
- Patient Capital Management's largest Q1 2026 buy was Adobe: 297,279 shares worth $72.3M.
- Patient Capital Management added most to Coinbase in Q1 2026, an estimated $49.5M increase.
- Patient Capital Management's biggest Q1 2026 reduction was Biogen, cutting an estimated $36.2M.
- Patient Capital Management fully exited Mattel in Q1 2026, selling an estimated $55.4M.
- Patient Capital Management's ten largest holdings make up 49% of its $2.74B portfolio in Q1 2026.
- Patient Capital Management opened 4 new positions and closed 4 in Q1 2026.
- Patient Capital Management's portfolio value rose 5.6% quarter-over-quarter to $2.74B.
Based on Patient Capital Management's 13F filing for Q1 2026, filed 14 May 2026.